Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioScrip Inc Issues FY 2013 Guidance Above Analysts' Estimates

Monday, 11 Mar 2013 04:45pm EDT 

BioScrip Inc announced that for fiscal 2013, it expects revenue to grow by 25% to 30% to a range of $830.0 million to $865.0 million and the Company is initially targeting adjusted EBITDA of $67.0 million to $73.0 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenues of $786 million and EBITDA of $64 million for fiscal 2013. 

Company Quote

0.03 +0.39%
4:00pm EDT